- Revenue rose 41% YoY to $203.0M, prompting a full-year 2026 guidance increase.
- Diluted EPS fell 30% YoY to $0.46 (GAAP) and 24% to $0.51 (Adjusted).
- Operating margin compressed 230 bps to 13.9% amid higher non-operating expenses.
Signal #149871 · SEC 8-K
$TMDX SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $TMDX filing catalyst
Why did $TMDX trigger an AI stock catalyst alert?
$TMDX triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -2.0/10). Headline: TransMedics Reports Q3 2026: Revenue +41% to $203M, Diluted EPS Drops 30% to $0.46. Key points: - Revenue rose 41% YoY to $203.0M, prompting a full-year 2026 guidance increase. - Diluted EPS fell 30% YoY to $0.46 (GAAP) and 24% to $0.51 (Adjusted). - Operating margin compressed 230 bps to 13.9% amid higher non-operating expenses.
How did $TMDX stock react after the SEC filing?
After the SEC 8-K for $TMDX, observed market reaction: T0 price $68.98. Past moves do not guarantee future results.
Where can I get real-time $TMDX SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $TMDX via Telegram and the VIP Web Terminal from €10/month.